Airborne bacteria pose a grave threat to patients undergoing surgery and surgical site infections (SSI) can be deadly. They always cause great harm and drive healthcare costs. Large resources are dedicated to ensure clean operating rooms where advanced surgery is performed. The ventilation system plays a key, but often misunderstood, role in here. Avidicare has developed the Opragon system, securing ultra clean air in a large and well defined zone, using proprietary temperature-control laminar airflow technology. The company is pioneering an evidence-based approach to operating room ventilation.

We are investing in Avidicare because we think this approach will win ground and set a new standard. We expect the technology to become widely used by leading surgical centres around the world. As bacteria resistant to antibiotics become an ever more dire threat, and a reality, it will be crucial to deploy effective and scientifically proven solutions in the operating theatre.